Nanobiotix is trading 5.08% up at $34.73 as broader markets rally.

  • On September 21, 2026, the Nasdaq Composite is up 2.13% and the S&P 500 is up 1.49%.
  • No new company-specific announcement clearly explains the move.
  • Recent positive JNJ-1900 clinical data and Guggenheim’s Buy initiation with a $64 target are supportive background factors, while the immediate move appears primarily tied to global risk appetite.